Centene

CNC Health Care Market cap $33.9B as of Oct 29, 2026 16:00 ET S&P 500

Q3 FY26 Jul 1 – Sep 30, 2026 reported Oct 27, 2026

Revenue$50.65B +2% year over year

Gross profit$3.30B 7% margin

Operating profit−$0.31B −1% margin

Net profit−$0.07B 0% margin

Net profit is larger than what operations earned, because the statement adds $0.24B below it, under Tax benefit and other.

The numbers behind the diagram

All figures in billions of U.S. dollars, for Q3 FY26 (period ends Sep 30, 2026).
Item	Value	Share of revenue	Year over year
Segment revenue	54.75	108%
Medicaid	31.97	63%
Medicare	11.06	22%
Commercial	9.36	19%
Other/Eliminations	1.20	2%
Other revenue	1.17	2%
Eliminations	−4.10	−8%
Net revenue	50.65	100%	+2%
Cost of revenue	−47.35	93%
Gross profit	3.30	7% margin	+0pp
SG&A	−3.24	6%	+0pp
Other	−0.37	1%	+0pp
Operating profit	−0.31	−1% margin	+13pp
Tax benefit and other	0.24
Net profit	−0.07	0% margin	+13pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
Item	Value	Share of revenue	Year over year
Revenue	53.58	100%	+10%
Medicaid	31.97	60%
Medicare	11.06	21%
Commercial	9.36	17%
Other/Eliminations	1.20	2%
Cost of revenue	−48.96	91%
Gross profit	4.62	9% margin	+2pp
SG&A	−3.10	6%	+0pp
Other	−0.32	0%	+0pp
Operating profit	1.20	2% margin	+3pp
Other income, net	0.29
Tax	−0.40
Net profit	1.09	2% margin	+3pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Mar 31, 2026).
Item	Value	Share of revenue	Year over year
Revenue	49.94	100%	+7%
Medicaid	23.60	47%
Medicare	10.33	21%	+18%
Commercial	9.56	19%	−6%
Other revenue	4.52	9%
Other/Eliminations	1.18	2%	−8%
Services	0.77	2%
Cost of revenue	−44.29	89%
Gross profit	5.65	11% margin	+0pp
SG&A	−3.40	7%	+0pp
Other	−0.39	1%	+0pp
Operating profit	1.86	4% margin
Other income, net	0.24
Tax	−0.56
Net profit	1.54	3% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q1 FY25 (period ends Mar 31, 2025).
Item	Value	Share of revenue	Year over year
Revenue	46.62	100%	+15%
Medicaid	26.43	56%
Commercial	10.15	22%
Medicare	8.76	19%
Other/Eliminations	1.28	3%
Cost of revenue	−41.33	89%
Gross profit	5.29	11% margin	+0pp
SG&A	−3.35	7%	−1pp
Other	−0.40	1%	+0pp
Operating profit	1.53	3% margin	+1pp
Other income, net	0.21
Tax	−0.43
Net profit	1.31	3% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

All figures in billions of U.S. dollars, for Q3 FY24 (period ends Sep 30, 2024).
Item	Value	Share of revenue	Year over year
Revenue	42.02	100%	+10%
Medicaid	26.44	63%
Commercial	8.69	21%
Medicare	5.64	13%
Other/Eliminations	1.25	3%
Cost of revenue	−38.02	90%
Gross profit	4.01	10% margin	−3pp
SG&A	−3.06	7%	−1pp
Other	−0.28	1%	+0pp
Operating profit	0.67	2% margin	+0pp
Other income, net	0.26
Tax	−0.21
Net profit	0.71	2% margin	+0pp

Figures are rounded to the precision shown, so a column can differ slightly from its own total.

Filing on EDGAR This quarter on its own page

Financial health

The balance sheet, the quarter's capital flow, the debt schedule and the capital structure of the quarter shown above.

Every set of results we hold, newest first. Open one on its own page.

Quarter	Period	Reported	Revenue	Year over year	Operating margin	Net profit	Net margin
Q3 FY26 Jul 1 – Sep 30, 2026 reported Oct 27, 2026 Operating margin −1% Net profit −$0.07B	Jul 1 – Sep 30, 2026	Oct 27, 2026	$50.6B	+2%	−1%	−$0.07B	0%
Q2 FY26 Apr 1 – Jun 30, 2026 reported Jul 28, 2026 Operating margin 2% Net profit $1.09B	Apr 1 – Jun 30, 2026	Jul 28, 2026	$53.6B	+10%	2%	$1.09B	2%
Q1 FY26 Jan 1 – Mar 31, 2026 reported Apr 28, 2026 Operating margin 4% Net profit $1.54B	Jan 1 – Mar 31, 2026	Apr 28, 2026	$49.9B	+7%	4%	$1.54B	3%
Q1 FY25 Jan 1 – Mar 31, 2025 reported Apr 25, 2025 Operating margin 3% Net profit $1.31B	Jan 1 – Mar 31, 2025	Apr 25, 2025	$46.6B	+15%	3%	$1.31B	3%
Q3 FY24 Jul 1 – Sep 30, 2024 reported Oct 25, 2024 Operating margin 2% Net profit $0.71B	Jul 1 – Sep 30, 2024	Oct 25, 2024	$42.0B	+10%	2%	$0.71B	2%